Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 30, 2019Cancer MedicineOpen Access

A five‐miRNA panel in plasma was identified for breast cancer diagnosis

View Full Paper
Ask AI
Bookmark
Share

Authors

MLMinghui LiHebei University of Science and TechnologyXZXuan ZouShenzhen Center for Disease Control and PreventionTXTiansong XiaNanjing Medical University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Li et al. (2019) studied this question.

synapsesocial.com/papers/6aaa1d96fbc95045e8f6ace0https://doi.org/10.1002/cam4.2572
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Plasma miR‐122 and miR‐200 family are prognostic markers in colorectal cancer2016 · 106 citations
  2. 2MicroRNA let‐7b regulates genomic balance by targeting Aurora B kinase2015 · 21 citations
  3. 3Technology in MicroRNA Profiling: Circulating MicroRNAs as Noninvasive Cancer Biomarkers in Breast Cancer2014 · 52 citations
  4. 4Mining of potential microRNAs with clinical correlation - regulation of syndecan-1 expression by miR-122-5p altered mobility of breast cancer cells and possible correlation with liver injury2018 · 45 citations